Appeal No. 2004-1040 Page 16 Application No. 09/770,643 Appellants also argue that the claimed polynucleotides are useful because of the disclosed polymorphism at position 812 of SEQ ID NO:1: “As polymorphisms such as this are the basis for forensic analysis, which is undoubtedly a ‘real world’ utility, the presently claimed sequences must in themselves be useful.” Appeal Brief, page 11. “The fact that forensic biologists use polymorphic markers such as that described by Appellants every day provides more tha[n] ample support for the assertion that forensic biologists would also be able to use the specific polymorphic marker described by Appellants in the same fashion.” Id., page 13. The lack of information regarding biological function is irrelevant to this utility, Appellants argues, because “[f]orensic analysis requires no information regarding the function of the protein encoded by the polymorphic DNA sequence.” Id., pages12-13. This argument is not persuasive because, among other things, it has no support in the specification or in the evidence of record. The specification discloses the presence of a polymorphism in SEQ ID NO:1 (page 14) but discloses no utilities based on detection of the polymorphism. In particular, the specification does not disclose that the polymorphism is a useful marker for forensic analysis. Appellants cite the specification at page 10, lines 15-19, as disclosing that “the present nucleic acids sequences have utility in forensic analysis.” Appeal Brief, page 11. We do not agree that this passage supports Appellants’ argument. The sentence cited by Appellants reads as follows: The identification and characterization of human genomic clones is helpful for identifying polymorphisms (including, but not limited to, nucleotide repeats, microsatellite alleles, single nucleotide polymorphisms, or coding single nucleotide polymorphisms), determining the genomic structure of a given locus/allele, and designing diagnostic tests.Page: Previous 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 NextLast modified: November 3, 2007